Surgery in the medical office setting can confer benefits for both the physician and the patient, as it can control costs, allow for flexibility in scheduling, and increase overall convenience.
Surgery in the medical office setting can confer benefits for both the physician and the patient, as it can control costs, allow for flexibility in scheduling, and increase overall convenience. As such, the prevalence of obstetric and gynecological surgical procedures being performed in the office setting has increased. Now, clinicians perform anything from infertility treatments and simple vulvar biopsies to hysteroscopies, D&C procedures and endometrial ablation-even though there are no regulations guiding patient safety principles for these increasingly complex procedures. So how does a clinician ensure good outcomes?
We invited Dr Bruce Ettinger, investigator and medical consultant in the Health Facilities Inspection Division of the Los Angeles County Department of Public Health, to share some insights and guidance for clinicians who wish to perform surgical procedures in their offices. As a consultant, Dr Ettinger evaluates issues in care quality and safety in ambulatory care and hospital settings, and has explored these issues as they pertain to the ob/gyn office setting in a poster presented at the American Congress of Obstetricians and Gynecologists’s annual meeting. Dr Ettinger is also board certified in obstetrics and gynecology and, before moving into his current role, had more than 35 years in clinical practice.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Excessive gonadotropins in IVF: Effects on mosaicism and live birth
April 12th 2024A recent study revealed a correlation between high doses and prolonged duration of exogenous gonadotropin use during in vitro fertilization and increased embryonic mosaicism alongside diminished live birth rates, prompting reconsideration of dosage and duration protocols.
Read More
Maternal history linked to uterine fibroid risk in Black women
April 11th 2024Delve into the findings of a recent study revealing the heightened risk of developing uterine fibroids among Black women with a maternal history of the condition, shedding light on crucial implications for patient care and advocacy.
Read More